Forward Look

Talking to doctors about cancer and its treatment often means being bombarded with numbers, from percentages to risk ratios. Yet many people don’t fully comprehend what the numbers mean. As a result, cancer patients may not understand their prognosis, the effect a treatment might have, or their risk for recurrence. Photo © iStock / PeterHermesFurian To […]

by Cameron Walker

Forward Look

Q&A with molecular biologist James DeGregori on cancer development.

by Sue Rochman

Forward Look

Breast cancer risk factor may be overlooked.

by Kendall K. Morgan

Forward Look

New recommendations support inclusion of teens in adult studies.

by Susan Kreimer

Forward Look

NCI-designated cancer centers play an important role in patient care.

by Kristine Meldrum Denholm

Forward Look

Financial factors can influence cancer patients' use of medications

by Kate Yandell

Forward Look

Researchers are studing new ways to keep treatments working longer.

by Stephen Ornes

More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.

by Sue Rochman

Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.

by Stephen Ornes

Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.

by Kate Yandell